Emma Betuel
Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio, an Israel-based startup that just closed a $50 million Series C round, argues that soon, a lot of that work could be...
Rating symptoms on a numerical scale seems easy, but it can be harder than it appears. How much did it hurt when you stubbed your toe? Was it a two out of 10? A four? How often do you wake up at night? Twice, three times? Regularly? Rarely?
These...
The next time your doorbell rings, it might be a DoorDash delivery, or one of a handful of startups all vying for grocery delivery supremacy. Or it might be a phlebotomist, ready to do your blood work in the comfort of your living room.
That roving phlebotomist is the...
The field scientists once jokingly called “blobography” has come a long way.
Cryogenic electron microscopy was formerly known for delivering amorphous images of biomolecules. Now it has become one of the highest fidelity methods available for viewing the body’s smallest building blocks. It’s also a key pillar of Gandeeva,...
It’s been a big two years for biotech investors. But if you ask Po Bronson, a partner at SOSV’s IndieBio, this trend was probably a long time coming.
“Often, the implication is that everything must be overpriced,” he tells TechCrunch. “But I think more of it is that some...
Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How can you understand life if you don’t look at it live?
“It was such a simple statement, but it...